Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Sg V Inhibitors

Chemical inhibitors of Sg V include a variety of compounds that interfere with specific cellular processes and protein interactions. Phosphoramidon acts as a metalloprotease inhibitor, which can inhibit the degradation of proteins that interact with Sg V, thereby potentially reducing Sg V activity due to altered protein interactions. On the other hand, Concanavalin A binds to glycoproteins and can alter glycosylation patterns. This binding can inhibit Sg V by affecting its glycosylation-dependent activity. Brefeldin A disrupts the protein transport from the endoplasmic reticulum to the Golgi apparatus, which can inhibit Sg V by preventing its proper trafficking and processing. In a similar vein, Monensin, an ionophore, disrupts intracellular pH and ion gradients, which can inhibit Sg V by interfering with its ion-dependent activity.

MG-132, a proteasome inhibitor, can lead to the accumulation of proteins that may bind and inhibit Sg V's activity within the cell. Genistein, a tyrosine kinase inhibitor, can inhibit phosphorylation-dependent signaling pathways, including those involving kinases that phosphorylate Sg V or its interacting partners, thereby inhibiting Sg V activity. E-64, a cysteine protease inhibitor, can prevent the cleavage of proteins that interact with or regulate Sg V, leading to inhibition of Sg V activity due to disrupted protein processing. Okadaic acid, a serine/threonine phosphatase inhibitor, can affect the dephosphorylation processes within the cell, potentially inhibiting Sg V by maintaining it in a phosphorylated and inactive state. Likewise, ALLN (Calpain Inhibitor I) can prevent the cleavage of proteins interacting with Sg V, potentially inhibiting its activity through the stabilization of its protein interactors. LY294002, a PI3K inhibitor, can inhibit the PI3K/Akt pathway, potentially reducing the phosphorylation of Sg V or its associated proteins, leading to inhibition of Sg V activity. Lastly, Staurosporine, a potent kinase inhibitor, can inhibit a broad range of kinases that may phosphorylate Sg V or proteins that modulate Sg V's activity, leading to a functional inhibition of Sg V.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Phosphoramidon

119942-99-3sc-201283
sc-201283A
5 mg
25 mg
$199.00
$632.00
8
(1)

This metalloprotease inhibitor can inhibit the degradation of proteins that may interact with Sg V, leading to a reduction in Sg V activity due to altered protein interactions.

Concanavalin A

11028-71-0sc-203007
sc-203007A
sc-203007B
50 mg
250 mg
1 g
$119.00
$364.00
$947.00
17
(2)

This lectin binds to glycoproteins altering glycosylation patterns, which can inhibit Sg V by affecting its glycosylation-dependent activity.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

This agent disrupts the protein transport from the endoplasmic reticulum to the Golgi apparatus, which can inhibit Sg V by preventing its proper trafficking and processing.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$155.00
$525.00
(1)

This ionophore disrupts intracellular pH and ion gradients, which can inhibit Sg V by interfering with its ion-dependent activity.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

This proteasome inhibitor can lead to an accumulation of proteins that may bind and inhibit Sg V's activity within the cell.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

This tyrosine kinase inhibitor can inhibit phosphorylation-dependent signaling pathways, which may include kinases that phosphorylate Sg V or its interacting partners, thereby inhibiting Sg V activity.

E-64

66701-25-5sc-201276
sc-201276A
sc-201276B
5 mg
25 mg
250 mg
$281.00
$947.00
$1574.00
14
(0)

This cysteine protease inhibitor can prevent the cleavage of proteins that interact with or regulate Sg V, leading to inhibition of Sg V activity due to disrupted protein processing.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

This serine/threonine phosphatase inhibitor can affect the dephosphorylation processes within the cell, potentially inhibiting Sg V by maintaining it in a phosphorylated and inactive state.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

This PI3K inhibitor can inhibit the PI3K/Akt pathway, potentially reducing the phosphorylation of Sg V or its associated proteins, leading to inhibition of Sg V activity.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

This potent kinase inhibitor can inhibit a broad range of kinases that may phosphorylate Sg V or proteins that modulate Sg V's activity, leading to a functional inhibition of Sg V.